JP2013233112A - Food and drink - Google Patents
Food and drink Download PDFInfo
- Publication number
- JP2013233112A JP2013233112A JP2012107791A JP2012107791A JP2013233112A JP 2013233112 A JP2013233112 A JP 2013233112A JP 2012107791 A JP2012107791 A JP 2012107791A JP 2012107791 A JP2012107791 A JP 2012107791A JP 2013233112 A JP2013233112 A JP 2013233112A
- Authority
- JP
- Japan
- Prior art keywords
- vinegar
- peptide
- component
- food
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 43
- 235000021419 vinegar Nutrition 0.000 claims abstract description 97
- 239000000052 vinegar Substances 0.000 claims abstract description 97
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 80
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 30
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 30
- 235000013336 milk Nutrition 0.000 claims abstract description 30
- 239000008267 milk Substances 0.000 claims abstract description 30
- 210000004080 milk Anatomy 0.000 claims abstract description 30
- 235000018102 proteins Nutrition 0.000 claims abstract description 28
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 24
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 19
- 241000251468 Actinopterygii Species 0.000 claims abstract description 14
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 10
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 10
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 6
- 235000008939 whole milk Nutrition 0.000 claims abstract description 6
- 239000005862 Whey Substances 0.000 claims abstract description 5
- 235000021119 whey protein Nutrition 0.000 claims abstract description 5
- 244000000231 Sesamum indicum Species 0.000 claims abstract description 4
- 235000008476 powdered milk Nutrition 0.000 claims abstract description 4
- 239000007857 degradation product Substances 0.000 claims description 33
- 239000000047 product Substances 0.000 claims description 25
- 235000013361 beverage Nutrition 0.000 claims description 11
- 230000017854 proteolysis Effects 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000013329 compounding Methods 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 21
- 235000019634 flavors Nutrition 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 238000000354 decomposition reaction Methods 0.000 abstract description 4
- 230000003405 preventing effect Effects 0.000 abstract description 4
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 235000019640 taste Nutrition 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 241000207961 Sesamum Species 0.000 description 15
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 235000010469 Glycine max Nutrition 0.000 description 10
- 229920001436 collagen Polymers 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 229960005069 calcium Drugs 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 235000001465 calcium Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 235000019606 astringent taste Nutrition 0.000 description 8
- 235000019658 bitter taste Nutrition 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- 239000001856 Ethyl cellulose Substances 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 4
- 108010011756 Milk Proteins Proteins 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 4
- 239000001639 calcium acetate Substances 0.000 description 4
- 235000011092 calcium acetate Nutrition 0.000 description 4
- 229960005147 calcium acetate Drugs 0.000 description 4
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 4
- 235000013539 calcium stearate Nutrition 0.000 description 4
- 239000008116 calcium stearate Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000019325 ethyl cellulose Nutrition 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- -1 fortifiers Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 235000010981 methylcellulose Nutrition 0.000 description 4
- 235000021239 milk protein Nutrition 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 3
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 229920001800 Shellac Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 229940082483 carnauba wax Drugs 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229960001681 croscarmellose sodium Drugs 0.000 description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001504519 Papio ursinus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000021420 balsamic vinegar Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 235000021427 coconut vinegar Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000021430 malt vinegar Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
Abstract
【課題】食酢は血圧上昇防止効果などの体調調節効果を発揮することが知られているが、特有の刺激臭を有するため、継続して有効量の食酢を摂取することが難しかった。本発明は、粉末状の食酢を含み、風味が改善された飲食品を提供することを目的とする。
【解決手段】本発明は成分(A):粉末状の食酢と、成分(B):タンパク質またはその分解物とを含有する飲食品を提供する。成分(A)は粉末状のトマト酢であることが好ましい。成分(B)は、ミルクペプチド、ゴマペプチド、豚ペプチド、魚ペプチド、大豆ペプチド、乳清タンパク質、ホエイパウダー、脱脂粉乳および全粉乳から選ばれる1種以上であることが好ましい。
【選択図】なし[PROBLEMS] It is known that vinegar exerts physical condition-controlling effects such as an effect of preventing blood pressure rise, but since it has a peculiar stimulating odor, it is difficult to continuously take an effective amount of vinegar. An object of this invention is to provide the food-drinks which contained powdery vinegar and were improved in flavor.
The present invention provides a food or drink containing component (A): powdered vinegar and component (B): protein or a decomposition product thereof. The component (A) is preferably powdered tomato vinegar. Component (B) is preferably at least one selected from milk peptide, sesame peptide, porcine peptide, fish peptide, soy peptide, whey protein, whey powder, skim milk powder and whole milk powder.
[Selection figure] None
Description
本発明は、飲食品に関する。 The present invention relates to food and drink.
食酢は種々の体調調節効果を有することが古くから知られている。体調調節効果としては例えば、消化液の分泌促進効果、疲労回復効果、糖尿病および肥満防止効果、血圧上昇防止効果、老化防止効果、血中エタノール濃度上昇防止効果、抗腫瘍効果などが報告されている。そのため、これらの効果を期待した食品の開発が従来から活発に行われている。しかし、食酢には特有の刺激臭があること、食酢の風味は必ずしも満足できる程度ではないことから、継続して有効量の食酢を摂取することが難しいという問題があった。 It has been known for a long time that vinegar has various physical condition control effects. Examples of physical condition regulating effects include digestive juice secretion promoting effect, fatigue recovery effect, diabetes and obesity preventing effect, blood pressure rising preventing effect, anti-aging effect, blood ethanol concentration rising preventing effect, antitumor effect, etc. . Therefore, the development of foods that expect these effects has been actively conducted. However, since vinegar has a peculiar pungent odor and the flavor of vinegar is not always satisfactory, there is a problem that it is difficult to continuously take an effective amount of vinegar.
特許文献1には、酢酸発酵で得たもろみ、食酢またはその分離残さを塩基性または中性カルシウム含有物質で処理することにより、酸性揮発性成分を中和して不揮発性塩とし、さらに必要に応じて脱脂、濃縮、乾燥または粉末化すること、および、これにより味覚改善が可能であることが記載されている。 In Patent Document 1, the volatile matter obtained by acetic acid fermentation, vinegar, or the separation residue thereof is treated with a basic or neutral calcium-containing substance to neutralize acidic volatile components to become a non-volatile salt, and further required It is described that degreasing, concentration, drying or pulverization can be performed accordingly, and that taste can be improved.
特許文献2には、粉末酢と、粉末ヒハツエキスおよび/または粉末生姜エキスと、賦形剤と、乳化剤とを含有する錠剤製品が、食べたときにむせることがないことが記載されている。 Patent Document 2 describes that a tablet product containing powdered vinegar, powdered baboon extract and / or powdered ginger extract, an excipient, and an emulsifier cannot be peeled when eaten.
しかし、特許文献1の方法では、まだ独特の刺激および収斂味が残り、改善の余地があった。特許文献2の技術では粉末酢摂食後のむせは回避されるものの、効果は剤形が錠剤の場合に限られており、粉末状の食酢そのままなど、錠剤以外の剤形における風味改善効果を目指すものではなかった。 However, the method of Patent Document 1 still has a unique stimulus and astringency, and there is room for improvement. Although the technique of Patent Document 2 avoids the insult after eating powdered vinegar, the effect is limited to the case where the dosage form is a tablet, and the aim is to improve the flavor in dosage forms other than tablets, such as powdered vinegar as it is It was not a thing.
本発明は、粉末状の食酢を含み、風味が改善された飲食品を提供することを目的とする。 An object of this invention is to provide the food-drinks which contained powdery vinegar and were improved in flavor.
本発明は下記の〔1〕〜〔5〕を提供する。
〔1〕成分(A):粉末状の食酢と、成分(B):タンパク質またはその分解物とを含有する飲食品。
〔2〕成分(A)が粉末状のトマト酢である上記〔1〕に記載の飲食品。
〔3〕成分(B)が、ミルクペプチド、ゴマペプチド、豚ペプチド、魚ペプチド、大豆ペプチド、乳清タンパク質、ホエイパウダー、脱脂粉乳および全粉乳から選ばれる1種以上である上記〔1〕または〔2〕に記載の飲食品。
〔4〕成分(B)がタンパク質の分解物であり、その90%以上が分子量20,000以下である上記〔1〕〜〔3〕のいずれか一項に記載の飲食品。
〔5〕成分(A)および成分(B)の配合比が、成分(A):成分(B)=1:0.1〜3である、上記〔1〕〜〔4〕のいずれか一項に記載の飲食品。
〔6〕コーティング剤をさらに含有し、剤形が錠剤である上記〔1〕〜〔5〕のいずれか一項に記載の飲食品。
The present invention provides the following [1] to [5].
[1] Component (A): a food or drink containing powdered vinegar and component (B): protein or a decomposition product thereof.
[2] The food or drink according to [1], wherein the component (A) is powdered tomato vinegar.
[3] The above [1] or [1] wherein the component (B) is at least one selected from milk peptide, sesame peptide, porcine peptide, fish peptide, soy peptide, whey protein, whey powder, skim milk powder and whole milk powder Food / beverage products of 2].
[4] The food or drink according to any one of [1] to [3] above, wherein the component (B) is a protein degradation product, and 90% or more thereof has a molecular weight of 20,000 or less.
[5] The mixing ratio of component (A) and component (B) is any one of the above [1] to [4], wherein component (A): component (B) = 1: 0.1-3 Food and drink as described in.
[6] The food or drink according to any one of [1] to [5], further including a coating agent and having a tablet dosage form.
本発明によれば、粉末状の食酢の風味が改善された飲食品が提供される。 According to this invention, the food / beverage products with which the flavor of the powdery vinegar was improved are provided.
成分(A)は粉末状の食酢である。食酢は一般に醸造酢と合成酢とに分類され、いずれを用いてもよいが、醸造酢が好ましい。醸造酢としては穀物酢および果実酢が挙げられる。穀物酢の例としては、米酢、麦酢、豆酢、とうもろこし酢、麦芽酢、黒酢、香酢などが挙げられる。果実酢の例としては、りんご酢、ぶどう酢、バルサミコ酢、トマト酢、ミカン酢、レモン酢、もも酢、かき酢、イチジク酢、バナナ酢、パイナップル酢、ココナッツ酢、ヤシ酢、サトウキビ酢、梅酢、蜂蜜酢、黒糖酢、柏酢などが挙げられる。これらのうち果実酢が好ましく、トマト酢がより好ましい。 Component (A) is a powdered vinegar. Vinegar is generally classified into brewed vinegar and synthetic vinegar, and any of them may be used, but brewed vinegar is preferred. Examples of brewed vinegar include grain vinegar and fruit vinegar. Examples of grain vinegar include rice vinegar, wheat vinegar, bean vinegar, corn vinegar, malt vinegar, black vinegar, and perfume vinegar. Examples of fruit vinegar include apple vinegar, grape vinegar, balsamic vinegar, tomato vinegar, orange vinegar, lemon vinegar, peach vinegar, kaki vinegar, fig vinegar, banana vinegar, pineapple vinegar, coconut vinegar, palm vinegar, sugarcane vinegar, Plum vinegar, honey vinegar, brown sugar vinegar, strawberry vinegar and the like. Of these, fruit vinegar is preferred, and tomato vinegar is more preferred.
食酢の製造方法は限定されない。通常、それぞれの食酢の原料を酢酸発酵して製造される。酢酸発酵の際には、公知の酢酸菌(アセトバクター属微生物など)が用いられうる。酢酸発酵やその他の発酵時における培養温度、時間等の培養条件、更には発酵菌種、培養方法等は、通常の発酵条件の範囲で、適宜選択して製造することができる。 The manufacturing method of vinegar is not limited. Usually, each raw material of vinegar is manufactured by acetic acid fermentation. In the case of acetic acid fermentation, a known acetic acid bacterium (Acetobacter microorganism or the like) can be used. Culture conditions such as culture temperature and time during acetic acid fermentation and other fermentation, as well as fermenting bacterial species, culture method, etc. can be appropriately selected and produced within the range of normal fermentation conditions.
成分(A)は、酢酸ナトリウム、酢酸カリウム、酢酸カルシウム等の酢酸塩を主成分とすることができるが、酢酸カルシウムを主成分とすることが好ましい。これにより、強い酸味、酸臭が低下し、嗜好性を高めることができる。酢酸カルシウムの含量は、40質量%以上が好ましく、50質量%以上がより好ましく、60質量%以上がさらに好ましい。 The component (A) can contain an acetate such as sodium acetate, potassium acetate or calcium acetate as a main component, but preferably contains calcium acetate as a main component. Thereby, a strong acidity and acid odor can fall and palatability can be improved. The content of calcium acetate is preferably 40% by mass or more, more preferably 50% by mass or more, and further preferably 60% by mass or more.
食酢から粉末状の食酢を製造する方法の例としては、特開昭61−100184号公報に記載の方法が挙げられる。この方法を簡潔に説明すると次の通りである。食酢に塩基性ないし中性カルシウム含有物質を混合溶解して中和し、篩過後、噴霧乾燥して粉末状の食酢を得る。この方法によれば、酢酸カルシウムを主成分とする粉末状の食酢を得ることができる。 Examples of a method for producing powdered vinegar from vinegar include the method described in JP-A-61-100184. This method is briefly described as follows. A basic or neutral calcium-containing substance is mixed and dissolved in vinegar to neutralize, and after sieving, spray-dried to obtain powdered vinegar. According to this method, powdered vinegar containing calcium acetate as a main component can be obtained.
塩基性または中性カルシウム含有物質の例としては、水酸化カルシウム、炭酸カルシウム、リン酸カルシウム、塩化カルシウム、クエン酸カルシウム、ピロリン酸カルシウム、グルコン酸カルシウム、乳酸カルシウム、ピロピオン酸カルシウム、ステアリン酸カルシウム、および、これらを主成分として含有する物質(卵殻焼成カルシウム、貝殻焼成カルシウム、石灰など)が挙げられる。塩基性ないし中性カルシウム含有物質の添加量は、pH7付近となる量が好ましい。 Examples of basic or neutral calcium-containing substances include calcium hydroxide, calcium carbonate, calcium phosphate, calcium chloride, calcium citrate, calcium pyrophosphate, calcium gluconate, calcium lactate, calcium pyropionate, calcium stearate, and these Substances contained as a main component (eg, eggshell calcined calcium, shell calcined calcium, lime, etc.) can be mentioned. The addition amount of the basic or neutral calcium-containing substance is preferably an amount that makes the pH around 7.
成分(A)は1種類の粉末状の食酢であってもよいし、原料、製法などを異にする2種類以上の粉末状の食酢の組み合わせであってもよい。 Component (A) may be one type of powdered vinegar, or may be a combination of two or more types of powdered vinegar with different raw materials, production methods, and the like.
成分(B)はタンパク質またはその分解物である。タンパク質またはその分解物は、食品のタンパク質またはその分解物であることが好ましい。食品のタンパク質としては、大豆、ゴマ等の植物タンパク質、ゼラチン、畜肉、魚肉、乳等の動物タンパク質が挙げられ、このうち動物タンパク質が好ましく、乳タンパク質がより好ましく、牛乳タンパク質がさらに好ましい。 Component (B) is a protein or a degradation product thereof. The protein or its degradation product is preferably a food protein or its degradation product. Examples of food proteins include plant proteins such as soybean and sesame, and animal proteins such as gelatin, livestock meat, fish meat, and milk. Of these, animal proteins are preferred, milk proteins are more preferred, and milk proteins are more preferred.
タンパク質の分解物はタンパク質の加水分解物が好ましく、加水分解酵素による加水分解物がより好ましい。加水分解物を得る際の加水分解の条件(例えば、加水分解酵素の種類、酵素の添加量、反応時間、反応温度、反応pHなど)は、タンパク質の種類などにより適宜設定することができる。 The protein degradation product is preferably a protein hydrolysis product, and more preferably a hydrolysis product of a hydrolase. Hydrolysis conditions (for example, the type of hydrolase, the amount of enzyme added, the reaction time, the reaction temperature, the reaction pH, etc.) for obtaining the hydrolyzate can be appropriately set depending on the type of protein.
タンパク質の分解物は、通常、単独では苦味を呈するが、本発明者らはタンパク質の分解物を粉末状の食酢と配合することにより、意外にも、タンパク質の分解物の苦味、粉末状の食酢の収斂味を改善できることを見出した。タンパク質の分解物は、タンパク質の分解物の集合体であってもよい。タンパク質の分解物は、その90%以上が分子量20,000以下であることが好ましく、5,000以下であることがより好ましい。タンパク質の分解物の90%以上が分子量20,000以下であるとは、ペプチドが2本以上の場合、全体の重量を100%としたときに、そのうちの90%のペプチドの1本あたりの分子量が20,000以下であることを意味する。ペプチドが1本の場合、そのペプチドの分子量が20,000以下であることを意味する。本発明において分子量の推定にはゲル濾過カラムを用いたHPLC法を用いることができる。測定条件の例としては、下記の例が挙げられる:
カラム:COSMOSIL 5Diol−300−H(ナカライテスク(株)) 7.5mmLD−600mm:
移動相:20mmol/L リン酸緩衝液(pH7.0)+100mmol/L Na2SO4、流速:1.0mL/min、検出:UV220nm。
分子量によっては、カラムをCOSMOSIL 5Diol−120−H(ナカライテスク(株)) 7.5mmLD−300mm等の他のカラムに適宜変更することもできる。
Protein degradation products usually exhibit a bitter taste alone, but the present inventors surprisingly combine the protein degradation product with powdered vinegar to produce a bitter taste of protein degradation product, powdered vinegar. It was found that the astringent taste of can be improved. The protein degradation product may be an aggregate of protein degradation products. 90% or more of the protein degradation product preferably has a molecular weight of 20,000 or less, and more preferably 5,000 or less. 90% or more of the protein degradation product has a molecular weight of 20,000 or less. When the number of peptides is 2 or more and the total weight is 100%, the molecular weight per 90% of the peptides Is 20,000 or less. When there is one peptide, it means that the molecular weight of the peptide is 20,000 or less. In the present invention, the HPLC method using a gel filtration column can be used for estimating the molecular weight. Examples of measurement conditions include the following:
Column: COSMOSIL 5Diol-300-H (Nacalai Tesque) 7.5 mm LD-600 mm:
Mobile phase: 20 mmol / L phosphate buffer (pH 7.0) +100 mmol / L Na 2 SO 4 , flow rate: 1.0 mL / min, detection: UV 220 nm.
Depending on the molecular weight, the column can be appropriately changed to another column such as COSMOSIL 5Diol-120-H (Nacalai Tesque) 7.5 mm LD-300 mm.
タンパク質またはその分解物は、純度の高いタンパク質またはその分解物自体であってもよいが、タンパク質またはその分解物を豊富に含む成分(例えば、食品の抽出物、加工品(全粉乳、脱脂粉乳)など)であれば純度は限定されない。 The protein or its degradation product may be a high-purity protein or its degradation product itself, but a component rich in the protein or its degradation product (eg, food extract, processed product (whole milk powder, skim milk powder) Etc.) Purity is not limited.
成分(B)は、ミルクペプチド、ゴマペプチド、豚ペプチド、魚ペプチド、大豆ペプチド、乳清タンパク質、ホエイパウダー、脱脂粉乳および全粉乳から選ばれる1種以上であることが好ましく、ミルクペプチド、ゴマペプチド、豚ペプチド、魚ペプチドおよび大豆ペプチドから選ばれる1種以上であることがより好ましく、ミルクペプチドであることがさらに好ましい。ミルクペプチド、ゴマペプチドは食酢と同様に血圧上昇抑制効果を有するので、これにより粉末状の食酢の風味を改善できるだけでなく、得られる飲食品において優れた血圧上昇抑制効果を発揮させることができる。 Component (B) is preferably at least one selected from milk peptide, sesame peptide, porcine peptide, fish peptide, soy peptide, whey protein, whey powder, skim milk powder and whole milk powder. More preferably, the peptide is one or more selected from pig peptide, fish peptide and soybean peptide, and more preferably milk peptide. Since milk peptides and sesame peptides have a blood pressure increase inhibitory effect in the same manner as vinegar, this can not only improve the flavor of powdered vinegar, but can also exhibit an excellent blood pressure increase inhibitory effect in the resulting food and drink.
ミルクペプチドは牛乳に含まれるタンパク質の分解物である。ミルクペプチドの製法は特に限定されないが、通常、カゼインをエンドペプチダーゼなどの酵素で加水分解して得られる。ミルクペプチドは、アンジオテンシン変換酵素(ACE)阻害活性を有することが好ましい(特許第3816921号公報など参照)。ミルクペプチドとしては市販品を用いることができ、市販品としては例えばミルクペプチドMKP(森永乳業株式会社製、質量分析により測定された分子量:3,000以下)を挙げることができる。 Milk peptides are degradation products of proteins contained in milk. The method for producing the milk peptide is not particularly limited, but it is usually obtained by hydrolyzing casein with an enzyme such as endopeptidase. The milk peptide preferably has an angiotensin converting enzyme (ACE) inhibitory activity (see, for example, Japanese Patent No. 3816921). As the milk peptide, a commercially available product can be used, and examples of the commercially available product include milk peptide MKP (manufactured by Morinaga Milk Industry Co., Ltd., molecular weight measured by mass spectrometry: 3,000 or less).
ゴマペプチドはゴマに含まれるタンパク質の分解物である。ゴマペプチドの製法は特に限定されないが、一例を挙げると次の通りである。まず脱脂されたゴマをアルカリ溶液で抽出し、酸による等電点沈殿によりゴマ由来のタンパク質を得る。ゴマ由来のタンパク質をサーモライシン等のプロテアーゼで酵素分解し、必要に応じて酵素分解後、清澄ろ過、濃縮、殺菌等の処理を行って、ゴマペプチドが得られる。ゴマペプチドはACE阻害活性を有することが好ましい(月刊フードケミカル、2002−3など参照)。ゴマペプチドとしては市販品を用いることができ、市販品としては例えばゴマペプチドKM−20(丸善製薬株式会社製、分子量:1800以下)を挙げることができる。 Sesame peptides are degradation products of proteins contained in sesame. The method for producing sesame peptide is not particularly limited, but an example is as follows. First, defatted sesame is extracted with an alkaline solution, and a sesame-derived protein is obtained by isoelectric precipitation with an acid. Sesame-derived protein is enzymatically decomposed with a protease such as thermolysin, and after enzymatic decomposition, if necessary, clarified filtration, concentration, sterilization and the like are performed to obtain a sesame peptide. The sesame peptide preferably has ACE inhibitory activity (see Monthly Food Chemical, 2002-3, etc.). A commercially available product can be used as the sesame peptide, and examples of the commercially available product include sesame peptide KM-20 (manufactured by Maruzen Pharmaceutical Co., Ltd., molecular weight: 1800 or less).
豚ペプチドは、豚の組織に含まれるタンパク質(例えば豚の(皮膚などに含まれる)コラーゲン)の分解物である。豚ペプチドとしては市販品を用いることができ、市販品としては例えば水溶性コラーゲンペプチドSS(協和発酵工業株式会社製、分子量(ピーク):5000)を用いることができる。 Porcine peptide is a degradation product of protein (for example, collagen (contained in skin etc.) of pig) contained in pig tissue. A commercially available product can be used as the porcine peptide. For example, a water-soluble collagen peptide SS (manufactured by Kyowa Hakko Kogyo Co., Ltd., molecular weight (peak): 5000) can be used.
魚ペプチドは、魚の組織に含まれるタンパク質(例えば魚の(鱗などに含まれる)コラーゲン)の分解物である。魚ペプチドとしては市販品を用いることができ、市販品としては例えば水溶性フィッシュコラーゲンペプチド(協和発酵工業株式会社製、分子量(ピーク):5000)を用いることができる。 The fish peptide is a degradation product of a protein (for example, collagen (contained in scales) of fish) contained in fish tissue. A commercially available product can be used as the fish peptide. For example, a water-soluble fish collagen peptide (manufactured by Kyowa Hakko Kogyo Co., Ltd., molecular weight (peak): 5000) can be used.
大豆ペプチドは、大豆に含まれるタンパク質の分解物である。大豆ペプチドとしては市販品を用いることができ、市販品としては例えばCSPHP(協和発酵工業株式会社製、分子量(ピーク):8000)を用いることができる。 Soy peptide is a degradation product of protein contained in soybean. A commercially available product can be used as the soybean peptide, and for example, CSPHP (manufactured by Kyowa Hakko Kogyo Co., Ltd., molecular weight (peak): 8000) can be used.
成分(B)は1種類のタンパク質またはその分解物であってもよいし、2種類以上のタンパク質または分解物であってもよいし、2種以上のタンパク質または分解物であってもよいし、1種類以上のタンパク質と1種類以上の分解物の組み合わせであってもよい。 Component (B) may be one type of protein or a degradation product thereof, may be two or more types of proteins or degradation products, may be two or more types of proteins or degradation products, A combination of one or more proteins and one or more degradation products may be used.
成分(A)に対する成分(B)の配合比(質量比)は、成分(A):成分(B)=1:0.1〜3であることが好ましく、成分(A):成分(B)=1:0.1〜2であることがより好ましく、成分(A):成分(B)=1:0.1〜1であることがさらに好ましい。これにより、粉末化した食酢の刺激臭が顕著に改善され得る。 The compounding ratio (mass ratio) of component (B) to component (A) is preferably component (A): component (B) = 1: 0.1-3, and component (A): component (B) = 1: 0.1-2 is more preferable, and component (A): component (B) = 1: 0.1-1 is more preferable. Thereby, the pungent odor of powdered vinegar can be remarkably improved.
本発明の飲食品の投与量は、本発明の効果を損なわない限り特に制限は無く、また適応される被投与生体の年齢、状態などの種々の要因により適宜変えることができる。目的の効果を得るためには、成人1人あたりの飲食品中の成分(A)の投与量として0.001g/日〜100g/日であることが好ましい。 The dose of the food or drink of the present invention is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately changed according to various factors such as the age and condition of the administration target organism. In order to obtain the desired effect, the dose of the component (A) in the food or drink per adult is preferably 0.001 g / day to 100 g / day.
本発明の飲食品は、上記成分(A)および成分(B)を含んでいればよく、成分(A)および成分(B)以外の成分を有していてもよい。その他の成分の一例としては、主に貯蔵および流通における安定性を確保する成分(例えば保存安定剤など)、目的の飲食品を構成する諸成分が挙げられる。 The food / beverage products of this invention should just contain the said component (A) and component (B), and may have components other than a component (A) and a component (B). As an example of another component, the component (for example, storage stabilizer etc.) which mainly ensures the stability in storage and distribution, and various components which comprise the target food-drinks are mentioned.
本発明の飲食品に含まれる、成分(A)および(B)以外の成分は、本発明の目的を損なわない限り、特に限定されない。例えば、油性成分、賦形剤、崩壊剤、結合剤、滑沢剤、コーティング剤、着色剤、発色剤、矯味剤、着香剤、酸化防止剤、防腐剤、呈味剤、酸味剤、甘味剤、強化剤、ビタミン剤、膨張剤、増粘剤、界面活性剤などの中から、製剤に必要な諸特性(例えば、製剤安定性)を損なわないものであって、最終製品である飲食品の剤形に応じたものを1種または2種以上選択することができる。 Components other than components (A) and (B) contained in the food and drink of the present invention are not particularly limited as long as the object of the present invention is not impaired. For example, oily ingredients, excipients, disintegrants, binders, lubricants, coating agents, colorants, coloring agents, flavoring agents, flavoring agents, antioxidants, preservatives, flavoring agents, sour agents, sweetness Food / beverage products that do not impair various properties (for example, formulation stability) necessary for the preparation from among agents, fortifiers, vitamins, swelling agents, thickeners, surfactants, etc. One type or two or more types according to the dosage form can be selected.
油性成分の例としては、脂肪酸エステル、炭化水素、高級脂肪酸、高級アルコール等が挙げられる。 Examples of the oil component include fatty acid esters, hydrocarbons, higher fatty acids, higher alcohols and the like.
賦形剤の例としては、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、結晶セルロース、エチルセルロース、低置換度ヒドロキシプロピルセルロース等のセルロース及びその誘導体、ポリビニルピロリドン、部分けん化ポリビニルアルコール等の合成高分子、ゼラチン、アラビアゴム末、プルラン、寒天、アルギン酸、アルギン酸ナトリウム、キタンサンガム等の多糖類、トウモロコシデンプン、バレイショデンプン、α化デンプン、ヒドロキシプロピルスターチ等のスターチおよびその誘導体、乳糖、果糖、ブドウ糖、白糖、トレハロース、パラチノース、マンニトール、ソルビトール、エリスリトール、キシリトール、還元パラチノース、粉末還元麦芽糖水飴、マルチトール等の糖類および糖アルコール類、軽質無水ケイ酸、微粒酸化ケイ素、酸化チタン、水酸化アルミニウムゲル等の無機賦形剤等が挙げられる。 Examples of excipients include hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, crystalline cellulose, ethylcellulose, cellulose such as low-substituted hydroxypropylcellulose and derivatives thereof, synthetic polymers such as polyvinylpyrrolidone and partially saponified polyvinyl alcohol, gelatin Polysaccharides such as gum arabic powder, pullulan, agar, alginic acid, sodium alginate, chitansan gum, starch such as corn starch, potato starch, pregelatinized starch, hydroxypropyl starch and derivatives thereof, lactose, fructose, glucose, sucrose, trehalose, Sugars and sugars such as palatinose, mannitol, sorbitol, erythritol, xylitol, reduced palatinose, powdered reduced maltose starch syrup, maltitol Alcohol acids, light anhydrous silicic acid, particulate silicon oxide, titanium oxide, and inorganic excipients such as aluminum hydroxide gel.
崩壊剤の例としては、クロスポビドン、カルメロースカルシウム、クロスカルメロースナトリウム、低置換度ヒドロキシプロピルセルロース、カルボキシメチルセルロース、カルボキシメチルスターチナトリウム、クロスカルメロースナトリウム、ヒドロキシプロピルスターチ、部分α化デンプン等が挙げられる。結合剤としては、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、エチルセルロース等のセルロース及びその誘導体、ポリビニルピロリドン、部分けん化ポリビニルアルコール等の合成高分子、ゼラチン、アラビアゴム末、プルラン、寒天、アルギン酸、アルギン酸ナトリウム、キタンサンガム等の多糖類等が挙げられる。 Examples of disintegrants include crospovidone, carmellose calcium, croscarmellose sodium, low-substituted hydroxypropyl cellulose, carboxymethyl cellulose, carboxymethyl starch sodium, croscarmellose sodium, hydroxypropyl starch, partially pregelatinized starch, etc. It is done. Binders include cellulose and its derivatives such as hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, ethylcellulose, synthetic polymers such as polyvinylpyrrolidone and partially saponified polyvinyl alcohol, gelatin, gum arabic powder, pullulan, agar, alginic acid, sodium alginate And polysaccharides such as kitan sang gum.
結合剤の例としては、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、エチルセルロース、ポリビニルアルコール、ポリビニルピロリドン、ゼラチン、デキストリン、デンプン、アルファー化デンプン等が挙げられる。 Examples of the binder include hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, ethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, gelatin, dextrin, starch, pregelatinized starch and the like.
滑沢剤の例としては、ステアリン酸カルシウム、ステアリン酸マグネシウム、ショ糖脂肪酸エステル、軽質無水ケイ酸、フマル酸ステアリルナトリウム、ポリエチレングリコール、タルク、ステアリン酸等が挙げられる。 Examples of lubricants include calcium stearate, magnesium stearate, sucrose fatty acid ester, light anhydrous silicic acid, sodium stearyl fumarate, polyethylene glycol, talc, stearic acid and the like.
本発明の飲食品の剤形の例としては、液状(液剤)、シロップ状(シロップ剤)、錠剤(錠剤、タブレット)、カプセル状(カプセル剤)、粉末状(顆粒、細粒)、ソフトカプセル状(ソフトカプセル剤)、シロップ状(シロップ剤)、固形状、半液体状、クリーム状、ペースト状が挙げられる。これらのうち飲料と区別される食品であることが好ましく、錠剤または粉末状の食品であることがより好ましく、錠剤であることがさらに好ましい。 Examples of the dosage form of the food and drink according to the present invention include liquid (liquid), syrup (syrup), tablet (tablet, tablet), capsule (capsule), powder (granule, fine granule), soft capsule (Soft capsule), syrup (syrup), solid, semi-liquid, cream, and paste. Of these, foods that are distinguished from beverages are preferred, tablets or powdered foods are more preferred, and tablets are even more preferred.
本発明の飲食品が錠剤の場合、コーティング剤によるコーティングがなされていることが好ましい。食酢粉末含有錠剤では通常、独特のにおいのマスキングを目的として、コーティングがなされることが多いが、コーティングにより崩壊時間の遅延(つまり吸収性の低下)が認められる。一方本発明においては、成分(A)に成分(B)を組み合わせることにより、崩壊時間を短縮させることができるので、本発明の飲食品は体内での吸収性が従来品より高い。 When the food / beverage products of the present invention are tablets, it is preferable that they are coated with a coating agent. In vinegar powder-containing tablets, a coating is usually made for the purpose of masking a unique odor, but a delay in disintegration time (that is, a decrease in absorbability) is observed due to the coating. On the other hand, in the present invention, by combining the component (A) with the component (B), the disintegration time can be shortened, so that the food and drink of the present invention has higher absorbability in the body than the conventional product.
コーティング剤としては、例えば、シェラック、カルナウバロウ、ツェイン、ヒドロキシプロピルメチルセルロース、ヒドロキシメチルセルロースフタレート、カルボキシメチルセルロース、酢酸フタル酸セルロース、メタクリル酸コポリマー、エチルセルロース、メチルセルロース、アミノアルキルメタアクリレートコポリマー、ビール酵母細胞壁(例えば商品名イーストラップ等)、タピオカデンプン、ゼラチン、ペクチン、アラビアゴム末、糖、キトサン、等が挙げられる。 Examples of the coating agent include shellac, carnauba wax, zein, hydroxypropylmethylcellulose, hydroxymethylcellulose phthalate, carboxymethylcellulose, cellulose acetate phthalate, methacrylic acid copolymer, ethylcellulose, methylcellulose, aminoalkyl methacrylate copolymer, brewer's yeast cell wall (for example, trade name) Yeast wrap), tapioca starch, gelatin, pectin, gum arabic powder, sugar, chitosan and the like.
本発明の飲食品が錠剤である場合の製造方法の例を以下に挙げる。一例を挙げると、成分(A)と成分(B)と、賦形剤(マルチトール、微粒酸化ケイ素など)、結合剤(ヒドロキシプロピルセルロースなど)等の原材料とを混合して造粒し、さらに滑沢剤(ステアリン酸カルシウムなど)を混合して打錠し、コーティング剤(シェラック、カルナウバロウなど)でコーティングする。
本発明の飲食品は、健康食品、機能性食品、健康食品、健康補助食品(サプリメント)、栄養補助食品、特定保健用食品、医療用食品、病者用食品、乳児用食品、介護用食品、高齢者用食品等の飲食品として利用することもできる。これらのうち、健康補助食品として利用することが好ましい。
The example of the manufacturing method in case the food-drinks of this invention are tablets is given below. For example, the ingredients (A) and (B) are mixed with raw materials such as excipients (such as maltitol and finely divided silicon oxide) and binders (such as hydroxypropylcellulose), and granulated. A lubricant (calcium stearate, etc.) is mixed and compressed into tablets, and coated with a coating agent (shellac, carnauba wax, etc.).
The food and drink of the present invention include health foods, functional foods, health foods, health supplements (supplements), nutritional supplements, foods for specified health use, medical foods, foods for the sick, foods for infants, foods for nursing care, It can also be used as food and drink such as food for the elderly. Among these, it is preferable to use as a health supplement.
本発明においては、タンパク質または分解物からなる、粉末状の食酢を含む飲食品用の風味改良剤も提供される。タンパク質または分解物は、成分(B)の項で説明したのと同様である。タンパク質または分解物は1種類のタンパク質またはその分解物であってもよいし、2種類以上のタンパク質または分解物であってもよいし、2種以上のタンパク質または分解物であってもよいし、1種類以上のタンパク質と1種類以上の分解物の組み合わせであってもよい。本発明の風味改良剤が添加される粉末状の食酢は、成分(A)の項で説明したのと同様である。粉末状の食酢を含む飲食品の種類は特に限定されない。例えば、飲料(清涼飲料、炭酸飲料、栄養飲料、粉末飲料、果実飲料、乳飲料、ゼリー飲料など)、菓子類(クッキー、ケーキ、ガム、キャンディー、タブレット、グミ、饅頭、羊羹、プリン、ゼリー、アイスクリーム、シャーベットなど)、水産加工品(かまぼこ、ちくわ、はんぺんなど)、畜産加工品(ハンバーグ、ハム、ソーセージ、ウィンナー、チーズ、バター、ヨーグルト、生クリーム、チーズ、マーガリン、発酵乳など)、スープ(粉末状スープ、液状スープなど)、主食類(ご飯類、麺(乾麺、生麺)、パン、シリアルなど)、調味料(マヨネーズ、ショートニング、ドレッシング、ソース、たれ、しょうゆなど)が挙げられる。 In this invention, the flavor improving agent for food-drinks containing the powdery vinegar which consists of protein or a decomposition product is also provided. The protein or degradation product is the same as described in the section of component (B). The protein or degradation product may be one type of protein or degradation product thereof, two or more types of protein or degradation product, two or more types of protein or degradation product, A combination of one or more proteins and one or more degradation products may be used. The powdery vinegar to which the flavor improving agent of the present invention is added is the same as described in the section of component (A). The kind of food / beverage products containing powdered vinegar is not specifically limited. For example, beverages (soft drinks, carbonated drinks, nutrition drinks, powdered drinks, fruit drinks, milk drinks, jelly drinks, etc.), confectionery (cookies, cakes, gums, candy, tablets, gummies, buns, sheep cakes, puddings, jelly, Ice cream, sherbet, etc.), processed fishery products (kamaboko, chikuwa, hanpen, etc.), processed livestock products (hamburg, ham, sausage, wiener, cheese, butter, yogurt, fresh cream, cheese, margarine, fermented milk, etc.), soup (Powder soup, liquid soup, etc.), staple foods (rice, noodles (dried noodles, raw noodles), bread, cereals, etc.), seasonings (mayonnaise, shortening, dressing, sauce, sauce, soy sauce, etc.).
実施例1−1〜1−9:ミルクペプチドによる粉末状のトマト酢の風味改善効果
<方法>
トマト酢に塩基性カルシウム含有物質を混合融解して中和し、篩過後、噴霧乾燥して得られた粉末状のトマト酢に、ミルクペプチドを、表1の各比で混合した。粉末状のトマト酢の量は5gとした。各サンプルの、粉末状のトマト酢に由来する収斂味、ミルクペプチドに由来する苦味および風味を5名で、以下の指標で評価した。結果を表1に示す。
Examples 1-1 to 1-9: Effect of improving flavor of powdered tomato vinegar with milk peptide <Method>
Tomato vinegar was mixed and melted with a basic calcium-containing substance, neutralized, sieved, and then mixed with powdered tomato vinegar obtained by spray drying, and milk peptides were mixed in the ratios shown in Table 1. The amount of powdered tomato vinegar was 5 g. The astringent taste derived from the powdered tomato vinegar, the bitterness and flavor derived from the milk peptide of each sample were evaluated by the following indicators by 5 persons. The results are shown in Table 1.
・粉末状のトマト酢の収斂味の改善度(5名の平均値)
1:3よりかなり味がよくなっている。
2:3より少し味がよくなっている。
3:粉末状のトマト酢のみ(比較例1)と同等
4:3より少し味が悪くなっている。
5:3よりかなり味が悪くなっている。
・ Improvement of astringent taste of powdered tomato vinegar (average value of 5 people)
The taste is considerably better than 1: 3.
A little better than 2: 3.
3: Equivalent to powdered tomato vinegar only (Comparative Example 1) The taste is slightly worse than 4: 3.
The taste is considerably worse than 5: 3.
・ミルクペプチドの苦味の改善度(5名の平均値)
1:3よりかなり味がよくなっている。
2:3より少し味がよくなっている。
3:ミルクペプチドのみ(比較例2)と同等
4:3より少し味が悪くなっている。
5:3よりかなり味が悪くなっている。
・ Improvement level of bitterness of milk peptide (average value of 5 people)
The taste is considerably better than 1: 3.
A little better than 2: 3.
3: Equivalent to milk peptide only (Comparative Example 2) The taste is slightly worse than 4: 3.
The taste is considerably worse than 5: 3.
・風味の改善度(5名の平均値)
1:3よりかなり味がよくなっている。
2:3より少し味がよくなっている。
3:粉末状のトマト酢のみ(比較例1)と同等
4:3より少し味が悪くなっている。
5:3よりかなり味が悪くなっている。
・ Degree of improvement in flavor (average of 5 people)
The taste is considerably better than 1: 3.
A little better than 2: 3.
3: Equivalent to powdered tomato vinegar only (Comparative Example 1) The taste is slightly worse than 4: 3.
The taste is considerably worse than 5: 3.
サンプルの各評価ポイントが3未満である場合に、そのサンプルの評価が良好であると判断した。 When each evaluation point of a sample was less than 3, the evaluation of the sample was judged to be good.
表1から、実施例1−1〜1−9においては、粉末状のトマト酢の収斂味またはミルクペプチドの苦味が改善されていることが明らかである。中でも実施例1−2〜1−7、とりわけ実施例1−3〜1−5では風味の顕著な改善が見られた。この結果は、本発明の飲食品は、成分(B)としてミルクペプチドを用いた場合、単独では苦味を有するミルクペプチドにもかかわらず粉末状のトマト酢の収斂味を改善することができることを示している。 From Table 1, it is clear that in Examples 1-1 to 1-9, the astringent taste of powdered tomato vinegar or the bitter taste of milk peptide was improved. Above all, in Examples 1-2 to 1-7, especially Examples 1-3 to 1-5, a significant improvement in flavor was observed. This result shows that the food / beverage product of the present invention can improve the astringent taste of powdered tomato vinegar in spite of milk peptide having a bitter taste alone when milk peptide is used as component (B). ing.
比較例1
サンプルを粉末状のトマト酢単独に替え、その味をパネラー5名で評価したところ、パネラー5名とも酢のこもるにおいおよび収斂味がした。
Comparative Example 1
When the sample was changed to powdered tomato vinegar alone and the taste was evaluated by five panelists, the five panelists both had a smell of vinegar and astringent taste.
比較例2
サンプルをミルクペプチド単独に替え、その味をパネラー5名で評価したところ、実施例1−1と同様に評価を行ったところ、パネラー5名とも苦みを感じた。
Comparative Example 2
When the sample was changed to the milk peptide alone and the taste was evaluated by 5 panelists, evaluation was performed in the same manner as in Example 1-1, and 5 panelists felt bitter.
実施例2−1〜2−5:様々なペプチドによる粉末状のトマト酢の風味改善効果
<方法>
表2に示す各種ペプチド(ミルクペプチド、ゴマペプチド、豚コラーゲンペプチド、魚コラーゲンペプチド、大豆ペプチド)を、粉末状のトマト酢と同量添加し、混合した。粉末状のトマト酢の量は5gとした。各サンプルの味をパネラー5名で、以下の指標で評価した。
Examples 2-1 to 2-5: Flavor improving effect of powdered tomato vinegar by various peptides <Method>
Various peptides shown in Table 2 (milk peptide, sesame peptide, porcine collagen peptide, fish collagen peptide, soybean peptide) were added in the same amount as powdered tomato vinegar and mixed. The amount of powdered tomato vinegar was 5 g. The taste of each sample was evaluated by the following indicators with 5 panelists.
1:3よりかなり味がよくなっている。
2:3より少し味がよくなっている。
3:粉末状のトマト酢のみ(比較例1)と同等
4:3より少し味が悪くなっている。
5:3よりかなり味が悪くなっている。
The taste is considerably better than 1: 3.
A little better than 2: 3.
3: Only powdery tomato vinegar (Comparative Example 1) is equivalent to 4: 3.
The taste is considerably worse than 5: 3.
表2から明らかな通り、実施例2−1〜2−4のいずれにおいても粉末状のトマト酢の風味が改善され、中でも実施例2−1においては顕著に改善した。この結果は、成分(B)としてミルクペプチド、ゴマペプチド、豚コラーゲンペプチド、魚コラーゲンペプチドまたは大豆ペプチドを用いることにより、粉末状のトマト酢独特の風味を軽減させられること、中でもミルクペプチドの効果が顕著であることを示している。 As is apparent from Table 2, the flavor of the powdered tomato vinegar was improved in any of Examples 2-1 to 2-4, and in Example 2-1 it was significantly improved. This result shows that by using milk peptide, sesame peptide, porcine collagen peptide, fish collagen peptide or soybean peptide as component (B), the unique flavor of powdered tomato vinegar can be reduced. It shows that it is remarkable.
比較例3〜6
サンプルをゴマペプチド(比較例3)、豚コラーゲンペプチド(比較例4)、魚コラーゲンペプチド(比較例5)および大豆ペプチド(比較例6)それぞれ単独に替えた。各ペプチドの量は5gとした。各サンプルの味をパネラー5名で評価したところ、パネラー5名とも苦味またはエグ味を呈した。上記実施例2−1〜2−5の結果と比較例3〜6の結果は、本発明の飲食品において、粉末状のトマト酢の収斂味だけでなくペプチドの苦味も改善されていることを示している。
Comparative Examples 3-6
Samples were replaced with sesame peptide (Comparative Example 3), porcine collagen peptide (Comparative Example 4), fish collagen peptide (Comparative Example 5) and soybean peptide (Comparative Example 6), respectively. The amount of each peptide was 5 g. When the taste of each sample was evaluated by 5 panelists, all 5 panelists exhibited a bitter taste or a delicious taste. The results of the above Examples 2-1 to 2-5 and the results of Comparative Examples 3 to 6 show that not only the astringent taste of powdered tomato vinegar but also the bitter taste of the peptide is improved in the food and drink of the present invention. Show.
実施例3−1〜3−5:乳タンパク質の、粉末状のトマト酢の風味改善効果
<方法>
粉末状のトマト酢に牛乳由来のタンパク質(ミルクペプチド(実施例3−1)、乳清タンパク(実施例3−2)、ホエイパウダー(実施例3−3)、脱脂粉乳(実施例3−4)、全粉乳(実施例3−5))を、粉末状のトマト酢と同量添加し、混合した。粉末状のトマト酢の量は5gとした。各サンプルの味を5名で、以下の指標で評価した。
Examples 3-1 to 3-5: Flavor improving effect of powdered tomato vinegar of milk protein <Method>
Milk-derived protein (milk peptide (Example 3-1), whey protein (Example 3-2), whey powder (Example 3-3), skim milk powder (Example 3-4) ), Whole milk powder (Example 3-5)) was added in the same amount as powdered tomato vinegar and mixed. The amount of powdered tomato vinegar was 5 g. The taste of each sample was evaluated by the following indicators by 5 people.
1:3よりかなり味がよくなっている。
2:3より少し味がよくなっている。
3:粉末状のトマト酢のみと同等
4:3より少し味が悪くなっている。
5:3よりかなり味が悪くなっている。
The taste is considerably better than 1: 3.
A little better than 2: 3.
3: Equivalent to only powdered tomato vinegar A little worse than 4: 3.
The taste is considerably worse than 5: 3.
表3から明らかな通り、実施例3−1〜3−5のいずれにおいても粉末状のトマト酢の風味が改善され、中でも実施例3−1においては顕著に改善した。この結果は、成分(B)として乳タンパク質またはその分解物を用いることにより、粉末状のトマト酢独特の風味を軽減させられること、中でもミルクペプチドの効果が顕著であることを示している。 As is clear from Table 3, the flavor of powdered tomato vinegar was improved in any of Examples 3-1 to 3-5, and in Example 3-1, it was significantly improved. This result indicates that the use of milk protein or its degradation product as component (B) can reduce the peculiar flavor of powdered tomato vinegar, and particularly the effect of milk peptide is remarkable.
実施例4−1〜4−2および比較例7:ミルクペプチド配合による崩壊性の向上効果
<試験方法>
粉末状のトマト酢1(質量比)に対し表4に示す各比率のミルクペプチドを混合した。得られた混合物に対して賦形剤(マルチトール)0.25(質量比)、さらに滑沢剤(ステアリン酸カルシウム)0.05(質量比)を添加して混合し、それぞれが互いに同程度の硬度になるよう打錠した。出来上がった各錠剤(n=6)の崩壊時間の測定を行い、平均値(ave.)を算出した。また、各錠剤の硬度の測定を行った。結果を表5に示す。
Examples 4-1 to 4-2 and Comparative Example 7: Effect of improving disintegration by adding milk peptide <Test method>
Milk powder of each ratio shown in Table 4 was mixed with powdered tomato vinegar 1 (mass ratio). To the obtained mixture, excipient (maltitol) 0.25 (mass ratio) and lubricant (calcium stearate) 0.05 (mass ratio) were added and mixed, and each was of the same level. Tableting was performed so that the hardness was reached. The disintegration time of each completed tablet (n = 6) was measured, and the average value (ave.) Was calculated. In addition, the hardness of each tablet was measured. The results are shown in Table 5.
錠剤の製造機器・条件・錠剤形状は下記のとおりである。
機械:sankyo piotech製 tabletting tester
錠剤の重量:500mg
打錠圧:600kg
錠剤の直径φ:110mm、厚さ:約4mm
The tablet manufacturing equipment, conditions, and tablet shape are as follows.
Machine: tableting tester made by sankyo piotech
Tablet weight: 500mg
Tableting pressure: 600kg
Tablet diameter φ: 110 mm, thickness: about 4 mm
錠剤の崩壊時間の測定は、16改正日本薬局方 6.07崩壊試験法に従って行った。錠剤の硬度は、Tablet Hardness Tester TypePTB301(PHARMA TEST社製)により評価した。 The disintegration time of the tablets was measured according to the 16th revised Japanese Pharmacopoeia 6.07 disintegration test method. The hardness of the tablet was evaluated by Tablet Hardness Tester Type PTB301 (manufactured by PHARMA TEST).
表4から明らかな通り、比較例7と比べて実施例4−1および4−2では、崩壊時間が1分以上短縮されていた。また、各実施例の値について有意差検定(t−検定)を行ったところ、実施例4−1と比較例7との間、実施例4−2と比較例7との間には、それぞれ有意差(p<0.01)があった。この結果は、成分(A)および成分(B)を含む飲食品の剤形が錠剤の場合、崩壊時間が顕著に短く、吸収性が非常に高いことが分かる。 As is clear from Table 4, in Examples 4-1 and 4-2, the disintegration time was shortened by 1 minute or more as compared with Comparative Example 7. Moreover, when the significant difference test (t-test) was performed about the value of each Example, between Example 4-1 and Comparative Example 7, between Example 4-2 and Comparative Example 7, respectively. There was a significant difference (p <0.01). This result shows that when the dosage form of the food and drink containing the component (A) and the component (B) is a tablet, the disintegration time is remarkably short and the absorbency is very high.
各実施例で用いた原材料に関する情報を表6に示した。 Table 6 shows information on raw materials used in each example.
Claims (6)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012107791A JP5937884B2 (en) | 2012-05-09 | 2012-05-09 | Food and drink |
CN201380022654.8A CN104270962B (en) | 2012-05-09 | 2013-04-22 | Beverage/food |
KR1020147022358A KR101892560B1 (en) | 2012-05-09 | 2013-04-22 | Food or drink |
PCT/JP2013/061753 WO2013168548A1 (en) | 2012-05-09 | 2013-04-22 | Food or drink |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012107791A JP5937884B2 (en) | 2012-05-09 | 2012-05-09 | Food and drink |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013233112A true JP2013233112A (en) | 2013-11-21 |
JP5937884B2 JP5937884B2 (en) | 2016-06-22 |
Family
ID=49550599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012107791A Expired - Fee Related JP5937884B2 (en) | 2012-05-09 | 2012-05-09 | Food and drink |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5937884B2 (en) |
KR (1) | KR101892560B1 (en) |
CN (1) | CN104270962B (en) |
WO (1) | WO2013168548A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016007209A (en) * | 2014-06-20 | 2016-01-18 | 株式会社えがお | Black vinegar-containing product, and tablet or capsule including the component |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106173775A (en) * | 2016-07-13 | 2016-12-07 | 天地壹号饮料股份有限公司 | A kind of vinegar powder solid sport drink and preparation method thereof |
CN108719806A (en) * | 2017-04-13 | 2018-11-02 | 荣海生物科技有限公司 | A kind of soybean peptide pudding and preparation method thereof |
CN107319447A (en) * | 2017-06-12 | 2017-11-07 | 福建农林大学 | A kind of reducing blood lipid jelly and preparation method thereof |
CN113115907A (en) * | 2019-12-31 | 2021-07-16 | 中粮营养健康研究院有限公司 | Small molecule peptide pudding and preparation method and application thereof |
CN116326673B (en) * | 2021-12-16 | 2024-12-13 | 深圳奥萨医药有限公司 | A protein combination that helps maintain healthy blood pressure levels |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6211060A (en) * | 1985-07-05 | 1987-01-20 | T Hasegawa Co Ltd | Improvement in flavor of food and drink |
JPH05111375A (en) * | 1991-10-23 | 1993-05-07 | Gun Ei Chem Ind Co Ltd | New powdery vinegar |
JP2000300190A (en) * | 1999-04-26 | 2000-10-31 | Fuji Oil Co Ltd | Food and drink with reduced bitterness |
JP2005198645A (en) * | 2003-05-22 | 2005-07-28 | Lion Corp | Fermented liquid of tomato, hypotensive agent, method for producing the same, and eating and drinking composition |
JP2006197911A (en) * | 2005-01-18 | 2006-08-03 | Yoshitaka Ito | Health food using bee larva |
WO2008004378A1 (en) * | 2006-07-03 | 2008-01-10 | Mizkan Group Corporation | Process for producing tomato vinegar and tomato vinegar |
JP2008073007A (en) * | 2006-09-25 | 2008-04-03 | Kyowa Hakko Kogyo Co Ltd | Vinegar corner control method |
JP2008148610A (en) * | 2006-12-15 | 2008-07-03 | Nisshin Oillio Group Ltd | Collagen-containing food product |
JP2009065842A (en) * | 2007-09-10 | 2009-04-02 | Meiji Milk Prod Co Ltd | Flavor improving method for food and drink having acidity and food and drink having acidity improved in flavor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07100022B2 (en) | 1984-10-19 | 1995-11-01 | 淳一 岩村 | healthy food |
JP2008017813A (en) | 2006-07-14 | 2008-01-31 | Nisshin Oillio Group Ltd | Vinegar-containing tablet food |
JP4727650B2 (en) * | 2007-12-29 | 2011-07-20 | 日清食品ホールディングス株式会社 | Nutritional supplements and health foods |
CN101700072B (en) * | 2009-11-13 | 2012-07-25 | 宁波大学 | Method for producing low-lactose milk beverage |
CN101715965B (en) * | 2009-12-04 | 2012-09-19 | 沈阳麦金利食品制造有限公司 | Fruit vinegar capsules and preparation method |
-
2012
- 2012-05-09 JP JP2012107791A patent/JP5937884B2/en not_active Expired - Fee Related
-
2013
- 2013-04-22 KR KR1020147022358A patent/KR101892560B1/en active IP Right Grant
- 2013-04-22 CN CN201380022654.8A patent/CN104270962B/en active Active
- 2013-04-22 WO PCT/JP2013/061753 patent/WO2013168548A1/en active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6211060A (en) * | 1985-07-05 | 1987-01-20 | T Hasegawa Co Ltd | Improvement in flavor of food and drink |
JPH05111375A (en) * | 1991-10-23 | 1993-05-07 | Gun Ei Chem Ind Co Ltd | New powdery vinegar |
JP2000300190A (en) * | 1999-04-26 | 2000-10-31 | Fuji Oil Co Ltd | Food and drink with reduced bitterness |
JP2005198645A (en) * | 2003-05-22 | 2005-07-28 | Lion Corp | Fermented liquid of tomato, hypotensive agent, method for producing the same, and eating and drinking composition |
JP2006197911A (en) * | 2005-01-18 | 2006-08-03 | Yoshitaka Ito | Health food using bee larva |
WO2008004378A1 (en) * | 2006-07-03 | 2008-01-10 | Mizkan Group Corporation | Process for producing tomato vinegar and tomato vinegar |
JP2008073007A (en) * | 2006-09-25 | 2008-04-03 | Kyowa Hakko Kogyo Co Ltd | Vinegar corner control method |
JP2008148610A (en) * | 2006-12-15 | 2008-07-03 | Nisshin Oillio Group Ltd | Collagen-containing food product |
JP2009065842A (en) * | 2007-09-10 | 2009-04-02 | Meiji Milk Prod Co Ltd | Flavor improving method for food and drink having acidity and food and drink having acidity improved in flavor |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016007209A (en) * | 2014-06-20 | 2016-01-18 | 株式会社えがお | Black vinegar-containing product, and tablet or capsule including the component |
Also Published As
Publication number | Publication date |
---|---|
CN104270962B (en) | 2017-06-06 |
WO2013168548A1 (en) | 2013-11-14 |
JP5937884B2 (en) | 2016-06-22 |
KR20150005906A (en) | 2015-01-15 |
KR101892560B1 (en) | 2018-08-28 |
CN104270962A (en) | 2015-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5937884B2 (en) | Food and drink | |
JP6991092B2 (en) | Sleep quality improver | |
WO2006132223A1 (en) | Anti-hypertensive composition | |
JP2008120754A (en) | Antifatigue agent | |
AU2018338277A1 (en) | Composition for promoting energy consumption | |
JP5053535B2 (en) | Oral for improving sleep or waking up | |
KR102538090B1 (en) | Food composition and health functional food containing Lactobacillus casei IDCC 3451 with proteolytic ability | |
JP2012082185A (en) | Collagens absorption promoter and its use | |
JP5885784B2 (en) | Oral composition | |
JP6129623B2 (en) | General nutrition food containing branched chain amino acids | |
JP2005097162A (en) | Anti-fatigue composition containing glutamine peptide | |
JP2009084191A (en) | Pharmacological composition for appetite suppression | |
JP4716769B2 (en) | Method for producing antihypertensive agent | |
JP7620606B2 (en) | Composition for lowering blood pressure and/or reducing neutral fat | |
JP2006335725A (en) | Composition for improving bloodstream | |
WO2019160024A1 (en) | Composition for reducing blood pressure and/or for reducing neutral fats | |
JPH0523134A (en) | Promoter for enhancing bone strength and foods containing the same | |
JP6964635B2 (en) | Orientation composition | |
JP6434312B2 (en) | Composition, food and drink, visceral fat reducing agent, blood sugar level reducing agent, food and drink for reducing visceral fat, and food and drink for reducing blood sugar level | |
JP2020152648A (en) | Composition for sympathetic nerve activation | |
JP2021187747A (en) | Composition for suppressing TGF-β | |
JP2021093932A (en) | Skin condition improving composition | |
JP2008156307A (en) | Angiotensin converting enzyme inhibitor, angiotensin converting enzyme inhibitor composition, and food and drink containing them | |
JPWO2007119590A1 (en) | Wheat-derived composition for lowering blood pressure | |
JP2006335708A (en) | Blood flow improving composition, and food and drink, feed, medicinal supplement and medicine containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140509 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141105 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160426 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160513 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5937884 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |